Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Apr 1;43(4):e475-e481.
doi: 10.1097/MAO.0000000000003465.

Long-term Prognosis of Vertigo Attacks and Health-related Quality of Life Limitations in Patients With Vestibular Paroxysmia

Lise A J Hanskamp  1 , Tjard R Schermer  1   2 , Roeland B van Leeuwen  1
Affiliations
Observational Study

Long-term Prognosis of Vertigo Attacks and Health-related Quality of Life Limitations in Patients With Vestibular Paroxysmia

Lise A J Hanskamp et al. Otol Neurotol. .

Abstract

Objective: To explore the long-term course of outcomes in vestibular paroxysmia (VP).

Study design: Cross-sectional observational study with a retrospective collection of baseline data.

Setting: Tertiary referral center.

Patients: Adult patients who visited the Apeldoorn Dizziness Center between 2010 and 2020 and were diagnosed with definite or probable VP according to the Bárány Society criteria were contacted by telephone to complete a study-specific questionnaire. Baseline data were retrospectively collected from patients electronic medical records to allow comparison between baseline and follow-up data.

Main outcome measures: Vertigo attack frequency, use of carbamazepine and health-related quality of life (HRQoL) limitations were the primary outcomes. Secondary outcomes were the number of attack-free years and perceived effect of medication for VP.

Results: Seventy three patients were included, 61 (84%) of whom agreed to participate in the follow-up study. Mean age was 55.0 (SD 13.1) years, 49.2% were females. Mean follow-up was 3.4 years (range 0.4-11.3). At follow-up, 44 responders (72%) still experienced vertigo attacks. Average attack frequency in the past 6 months was 307 (SD 451) at baseline and 153 (SD 279) at follow-up (p = 0.050). At follow-up, 19.7% (n = 12) of the responders reported to use or have used carbamazepine, 58% of patients who (had) used this medication reported a positive perceived effect. Overall, 71% (n = 31) of the responders reported to have limitations in one or more HRQoL items due to their VP.

Conclusion: Our study shows a rather unfavorable prognosis in patients with VP in terms of vertigo attacks and HRQoL limitations. After the initial diagnosis follow-up is warranted to monitor clinical outcomes in these patients.

PubMed Disclaimer

Conflict of interest statement

The authors disclose no conflicts of interest.

References

    1. Strupp M, Lopez-Escamez JA, Kim JS, et al. Vestibular paroxysmia: diagnostic criteria. J Vestib Res 2016; 26:409–415.
    1. Brandt T, Strupp M, Dieterich M. Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome. J Neurol 2016; 263: (Suppl 1): S90–S96.
    1. Karamitros A, Kalamatianos T, Stranjalis G, Anagnostou E. Vestibular paroxysmia: clinical features and imaging findings; a literature review. J Neuroradiol 2021; S0150-9861(21)00140-1.
    1. Teh CS, Noordiana SH, Shamini S, Prepageran N. Vascular loops: the innocent bystander for vestibular paroxysmia. Ann Otol Rhinol Laryngol 2021; 34894211037211.
    1. Sivarasan N, Touska P, Murdin L, Connor S. MRI findings in vestibular paroxysmia—An observational study. J Vestib Res 2019; 29:137–145.

Publication types